Source: Congenica Blog

Congenica Blog The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology

Philip Beer, Chief Scientific Officer of Step Pharma, Paris, and Honorary Professor of Translational Medicine in York, presented a webinar exploring one of the key challenges that we are currently facing when applying genomic testing in cancer. In this blog post, we will highlight the key takeaway messages from his webinar.  

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Robert Denison's photo - CEO of Congenica

CEO

Robert Denison

CEO Approval Rating

79/100

Read more